DIN 02169991 — LOXAPAC IM 50 MG
LOXAPAC IM is a solution of Loxapine marketed by SANDOZ CANADA INCORPORATED. The full Loxapine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02169991
- Brand name
- LOXAPAC IM
- Active ingredient
- Loxapine
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Antipsychotic (first-generation, dibenzoxazepine)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Loxapine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02230838 | XYLAC | 10 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |
| 02242868 | XYLAC | 2.5 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |
| 02230839 | XYLAC | 25 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED |
| 02230837 | XYLAC | 5 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT |
| 02230840 | XYLAC | 50 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT |